References
- Thein SL. The molecular basis of β-thalassemia. Cold Spring Harb Perspect Med. 2013;3(5):a011700
- Danjou F, Anni F, Galanello R. Beta-thalassaemia: from genotype to phenotype. Haematologica. 2011;96(11):1573–1575.
- Pornprasert S, Tookjai M, Punyamung M, et al. Proficiency testing program for Hemoglobin E, A2 and F analysis in Thailand using lyophilized hemoglobin control materials. Clin Chem Lab Med. 2018;56(4):602–608.
- Xu LH, Fang JP. The current status of β-thalassemia major in Mainland China. Hemoglobin. 2013;37(4):307–314.
- Zhang J, Yang Y, Li P, et al. Analysis of deletional hereditary persistence of fetal hemoglobin/δβ-thalassemia and δ-globin gene mutations in Southerwestern China. Mol Genet Genomic Med. 2019;7(6):e706.
- El-Latif MA, Filon D, Rund D, et al. The β+-IVS-I-6 (T>C) mutation accounts for half of the thalassemia chromosomes in the Palestinian populations of the mountain regions. Hemoglobin. 2002;26(1):33–40.
- Bonne B. Genes and phenotypes in the Samaritan isolate. Am J Phys Anthropol. 1966;24(1):1–19.
- Chen B, Huang P, Yi S, et al. First detection of a splice site β-thalassemia mutation, IVS-I-6 (T>C) (HBB: c.92+6T>C) in a Chinese family. Hemoglobin. 2015;39(3):207–208.
- Waye JS, Eng B, Patterson M, et al. Severity of β-thalassemia due to genotypes involving the IVS-I-6 (T→C) mutation. Am J Hematol. 1995;50(1):15–19.